MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
349.53%
Quick Ratio
316.40%
Cash Ratio
67.12%
Debt to Asset Ratio
55.72%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Trade receivables, net
    • Others
Liabilities Breakdown
    • Additional paid-in-capital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
227,033 198,693 295,694 186,193
Restricted cash
5,155 5,090 5,000 5,000
Marketable securities
585,738 784,866 814,055 610,831
Trade receivables, net
187,356 134,476 113,285 79,231
Inventory
112,070 74,841 69,317 63,497
Prepaid expenses and other current assets
64,955 47,804 49,329 58,604
Total current assets
1,182,307 1,245,770 1,346,680 1,003,356
Property and equipment, net
8,035 1,499 2,913 1,615
Intangible assets, net
7,284 7,381 7,477 4,548
Operating lease right-of-use assets
6,203 4,939 5,387 5,862
Other noncurrent assets
23,498 NaN NaN NaN
Total assets
1,227,327 1,259,589 1,362,457 1,015,381
Accounts payable
60,801 48,878 44,941 37,975
Accrued liabilities
275,761 260,392 345,382 157,479
Operating lease liabilities
1,697 1,018 1,083 1,049
Total current liabilities
338,259 310,288 391,406 196,503
Loan payable, net of discount
340,330 339,881 339,753 118,376
Operating lease liabilities, net of current portion
5,284 6,731 5,566 4,524
Total long term liabilities
345,614 346,612 345,319 122,900
Total liabilities
683,873 656,900 736,725 319,403
Common stock, par value 0.0001 per share authorized 200,000,000 shares at march31, 2026 and december31, 2025 23,041,918 and 22,842,073 shares issued and outstanding at march31, 2026 and december31, 2025, respectively
2 2 2 2
Additional paid-in-capital
2,727,227 2,692,280 2,656,553 2,612,566
Accumulated other comprehensive income
1,082 873 1,068 1,111
Accumulated deficit
-2,184,857 -2,090,466 -2,031,891 -1,917,701
Total stockholders equity
543,454 602,689 625,732 695,978
Total liabilities and stockholders equity
1,227,327 1,259,589 1,362,457 1,015,381
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$585,738K Cash and cashequivalents$227,033K Trade receivables,net$187,356K Inventory$112,070K Prepaid expenses andother current assets$64,955K Restricted cash$5,155K Total current assets$1,182,307K Other noncurrentassets$23,498K Property and equipment,net$8,035K Intangible assets, net$7,284K Operating leaseright-of-use assets$6,203K Total assets$1,227,327K Total liabilities andstockholders equity$1,227,327K Total liabilities$683,873K Total stockholdersequity$543,454K Accumulated deficit-$2,184,857K Total long termliabilities$345,614K Total currentliabilities$338,259K Additionalpaid-in-capital$2,727,227K Accumulated othercomprehensive income$1,082K Common stock, par value0.0001 per share...$2K Loan payable, net ofdiscount$340,330K Operating leaseliabilities, net of current...$5,284K Accrued liabilities$275,761K Accounts payable$60,801K Operating leaseliabilities$1,697K

MADRIGAL PHARMACEUTICALS, INC. (MDGL)

MADRIGAL PHARMACEUTICALS, INC. (MDGL)